[144] Agilent Technologies Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Agilent Technologies, Inc. (A) discloses a proposed sale of 15,303 common shares through Fidelity Brokerage Services (NYSE) with an aggregate market value of $1,968,223.83, and records prior sales by the same person. The shares to be sold were acquired as restricted stock that vested in November 2021 in four tranches (1,899; 10,935; 689; 1,780). The filing lists a prior sale by Robert W. McMahon of 28,081 shares on 08/29/2025 for gross proceeds of $3,508,994.14. The notice includes the seller's certification that they are not aware of undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of proposed insider sale including broker, share count, and aggregate market value
• Acquisition history provided showing shares were received as compensation via restricted stock vesting in November 2021
• Filing includes seller certification that no undisclosed material adverse information is known

Negative

• Significant insider sales disclosed: prior sale of 28,081 shares for $3,508,994.14 and proposed sale of 15,303 shares (~$1.97M) which may be viewed negatively by some investors

Insights

Securities Analyst

TL;DR Insider sale disclosed: 15,303 shares proposed for sale, previously sold 28,081 shares in August 2025.

The Form 144 provides a routine disclosure of an insider's intent to sell vested restricted shares through a broker on the NYSE. The aggregate value of the proposed sale (~$1.97M) and the recent realized sale (~$3.51M) are sizable in absolute terms but must be viewed relative to Agilent's market capitalization to assess materiality. The acquisition entries show these were compensation-related restricted stock vesting events from November 2021, indicating no recent purchase activity. The document contains standard certifications and no additional company-specific operational or financial disclosures.

Corporate Governance Specialist

TL;DR Disclosure aligns with Rule 144 requirements; shows insider liquidity from vested compensation.

The filing meets Rule 144 reporting norms by identifying the shares, broker, acquisition dates, and nature of acquisition as restricted stock vesting. It records a recent, substantial sale by Robert W. McMahon in August 2025 and a planned sale in September 2025. From a governance perspective, the filing demonstrates procedural compliance and transparency. The statement that the signer is unaware of undisclosed material adverse information is included, but the filing does not provide any operational detail about the issuer to evaluate broader governance implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15303	1968223.83	283500427	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2021	Restricted Stock Vesting	Issuer			1899	11/13/2021	Compensation
Common	11/16/2021	Restricted Stock Vesting	Issuer			10935	11/16/2021	Compensation
Common	11/17/2021	Restricted Stock Vesting	Issuer			689	11/17/2021	Compensation
Common	11/19/2021	Restricted Stock Vesting	Issuer			1780	11/19/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert W. Mcmahon 5301 Stevens Creek Blvd. Santa Clara CA 95051	Common	08/29/2025	28081	3508994.14

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Agilent Technologies (A) disclose?

It discloses a proposed sale of 15,303 common shares through Fidelity with an aggregate market value of $1,968,223.83 and prior sale of 28,081 shares on 08/29/2025 for $3,508,994.14.

Who is the seller named in this filing?

The filing records a prior seller as Robert W. McMahon and lists the proposed sale tied to the person for whose account the securities are to be sold.

How were the shares being sold originally acquired?

The shares were acquired as restricted stock that vested in November 2021 in four tranches totaling 15,303 shares, with payment characterized as compensation.

When is the proposed sale scheduled?

The approximate date of sale listed for the proposed transaction is 09/04/2025 on the NYSE via Fidelity Brokerage Services.

Does the filing indicate any undisclosed material information about Agilent?

The seller signs a certification representing they do not know any material adverse information about the issuer that has not been publicly disclosed.